Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-07-29
2011-11-15
Wang, Shengjun (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S279000
Reexamination Certificate
active
08058268
ABSTRACT:
Disclosed herein are methods of treating neurodegenerative diseases comprising administering to the subject a compound having the structure:wherein α and R1-R8are described herein, or a compound having the structure:wherein Y, Z, and R21, R24, R25, and R31-R33are described herein.
REFERENCES:
patent: 4143054 (1979-03-01), Sprague
patent: 4218478 (1980-08-01), Omura et al.
patent: 4298752 (1981-11-01), Dauben et al.
patent: 4463015 (1984-07-01), Haslanger et al.
patent: 4614825 (1986-09-01), Snitman et al.
patent: 4654355 (1987-03-01), Nakane et al.
patent: 4690918 (1987-09-01), Beppu et al.
patent: 4851423 (1989-07-01), Girijavallabhan et al.
patent: 4851553 (1989-07-01), Thottathil
patent: 5266710 (1993-11-01), Patel et al.
patent: 5326898 (1994-07-01), Chandraratna
patent: 5763647 (1998-06-01), Ohtani et al.
patent: 5770382 (1998-06-01), Hwang et al.
patent: 5925651 (1999-07-01), Hutchinson
patent: 5968965 (1999-10-01), Dinsmore et al.
patent: 6222055 (2001-04-01), Wolter et al.
patent: 6632823 (2003-10-01), Vernier et al.
patent: 6696483 (2004-02-01), Singh
patent: 6706762 (2004-03-01), Evans et al.
patent: 6777217 (2004-08-01), Schreiber et al.
patent: 6949624 (2005-09-01), Liu et al.
patent: 7067551 (2006-06-01), Remiszewski et al.
patent: 7154002 (2006-12-01), Bressi et al.
patent: 2002/0115826 (2002-08-01), Delorme et al.
patent: 2002/0147345 (2002-10-01), El Tayer et al.
patent: 2002/0177692 (2002-11-01), Bartel
patent: 2003/0162186 (2003-08-01), Bejanin et al.
patent: 2004/0087657 (2004-05-01), Richon et al.
patent: 2004/0106141 (2004-06-01), Mischel et al.
patent: 2004/0122101 (2004-06-01), Miller et al.
patent: 2004/0161475 (2004-08-01), Ellison et al.
patent: 2004/0197888 (2004-10-01), Armour et al.
patent: 2004/0209934 (2004-10-01), McCluskey et al.
patent: 2004/0253637 (2004-12-01), Buechler et al.
patent: 2005/0014839 (2005-01-01), Kozikowski et al.
patent: 2005/0020831 (2005-01-01), Inman et al.
patent: 2005/0054626 (2005-03-01), Carter et al.
patent: 2005/0136090 (2005-06-01), Falotico et al.
patent: 2005/0171202 (2005-08-01), Graupner et al.
patent: 2005/0203082 (2005-09-01), Hsu et al.
patent: 2005/0215526 (2005-09-01), Hulme et al.
patent: 2005/0222013 (2005-10-01), Jung et al.
patent: 2005/0272644 (2005-12-01), Chung
patent: 2005/0277583 (2005-12-01), Yoshida et al.
patent: 2006/0030616 (2006-02-01), McCluskey et al.
patent: 2006/0117994 (2006-06-01), Ryu et al.
patent: 2006/0134682 (2006-06-01), Robert et al.
patent: 2006/0167103 (2006-07-01), Bacapoulos et al.
patent: 2006/0235231 (2006-10-01), Joel et al.
patent: 2006/0264415 (2006-11-01), Leit de Moradei et al.
patent: 2007/0004771 (2007-01-01), Lee et al.
patent: 2007/0010669 (2007-01-01), Breslow et al.
patent: 2007/0049576 (2007-03-01), Barlow et al.
patent: 2007/0135365 (2007-06-01), Tanizawa et al.
patent: 2007/0135433 (2007-06-01), Dean et al.
patent: 2007/0155751 (2007-07-01), Paruch et al.
patent: 2007/0197550 (2007-08-01), Georgopapadakou et al.
patent: 2007/0208166 (2007-09-01), Baly et al.
patent: 2007/0213330 (2007-09-01), Delorme et al.
patent: 2008/0132503 (2008-06-01), Moradei et al.
patent: 2008/0214569 (2008-09-01), Zhuang et al.
patent: 2009/0012066 (2009-01-01), Izumo et al.
patent: 2009/0018142 (2009-01-01), Zhuang et al.
patent: 2009/0035292 (2009-02-01), Kovach et al.
patent: 2009/0036309 (2009-02-01), Kovach et al.
patent: 2009/0143445 (2009-06-01), Kovach et al.
patent: 2010/0029484 (2010-02-01), Kovach et al.
patent: 2010/0029683 (2010-02-01), Kovach et al.
patent: 1443967 (2007-01-01), None
patent: 2007511528 (2007-05-01), None
patent: 2007514665 (2007-06-01), None
patent: WO 2005018673 (2005-03-01), None
patent: WO 2005049084 (2005-06-01), None
patent: WO 2005054257 (2005-06-01), None
patent: WO 2005058280 (2005-06-01), None
patent: WO 2005074941 (2005-08-01), None
patent: WO 2006023603 (2006-03-01), None
patent: WO 2006129105 (2006-12-01), None
patent: WO 2007014029 (2007-02-01), None
patent: WO 2007021682 (2007-02-01), None
patent: WO 2007118137 (2007-10-01), None
International Search Report in connection with PCT/US09/04378, issued Sep. 18, 2009.
Written Opinion in connection with PCT/US09/04378, issued Sep. 18, 2009.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Search Authority, or the Declaration, in connection with PCT/US09/04378, issued Sep. 18, 2009.
Notification of Transmittal of the International Preliminary Report on patentability, in connection with PCT/US09/04378, issued Feb. 1, 2011.
International Preliminary Report on patentability, in connection with PCT/US09/04378, issued Feb. 1, 2011.
PCT International Application Publication WO/2007/092414, published Aug. 16, 2007.
International Search Report in connection with PCT/US2007/003095, issued Feb. 14, 2008.
International Preliminary Report on Patentability in connection with PCT/US2007/003095, issued Aug. 12, 2008.
Written Opinion in connection with PCT/US2007/003095, issued Feb. 14, 2008.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration in connections with PCT/US07/03095, issued Feb. 14, 2008.
Notification Concerning Transmittal of International Preliminary Report on Patentability in connection with PCT/US07/03095, issued Aug. 21, 2008.
PCT International Application Publication No. WO 2008/097561, published Aug. 14, 2008.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration in connection with PCT/US08/01549, issued May 16, 2008.
International Search Report in connection with PCT/US08/01549, issued May 16, 2008.
Written Opinion in connection with PCT/US08/01549, issued May 16, 2008.
PCT International Application Publication No. WO 2009/020565, published Feb. 12, 2009.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration in connection with PCT/US08/09330, issued Nov. 4, 2008.
International Search Report in connection with PCT/US08/09330, issued Nov. 4, 2008.
Written Opinion in connection with PCT/US08/09330, issued Nov. 4, 2008.
PCT International Application Publication No. WO 2009/045440, published Apr. 9, 2009.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration in connection with PCT/US08/11367, issued Dec. 12, 2008.
International Search Report in connection with PCT/US08/11367, issued Dec. 12, 2008.
Written Opinion in connection with PCT/US08/11367, issued Dec. 12, 2008.
Bastien et al. (2004) “Nuclear retinoid receptors and the transcription of retinoid-target genes.” Gene vol. 328, pp. 1-16.
Blaheta, A. et al. (2002), “Valproate and Valproate-Analogues: potent Tools to Fight Against Cancer,” Current Medicinal Chemistry, vol. 9 pp. 1417-1344.
Blaskovich et al. “Recent discovery and development of protein tyrosine phosphatase inhibitors.” Expert Opinion on Therapeutic Patents. 2002, vol. 12, No. 6, pp. 871-905.
Camphausen et al. (2005) “Influence of in vivo growth on human glioma cell line gene expression: Convergent profiles under orthotopic conditions.” Proc. Natl. Acad. Sci. USA, vol. 102, No. 23, pp. 8287-8292.
Drewinko et al. (1967), “Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells,” Cancer Biochem. Biophys., vol. 1, pp. 187-195.
Erdodi et al. (1995), “Endothal thioanhydride inhibits proteins phosphatases-1 and -2A inhibition, and anticancer activity,” Am. J. Physol. (Cell Physiol.) vol. 38, pp. C1176-C1184.
Flicker et al. “Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-a in SK-BR-3 breast cancer cells.” Cancer Lett. 1997, vol. 115, pp. 63-72.
Giannini, R. and Cavallini, A. (2005), “Expre
Claytor Renee
Cooper & Dunham LLP
Lixte Biotechnology, Inc.
Wang Shengjun
White John P.
LandOfFree
Neuroprotective agents for the prevention and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuroprotective agents for the prevention and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotective agents for the prevention and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4271911